跳至主要内容
临床试验/NCT04020679
NCT04020679终止不适用

A Hybrid Implementation-effectiveness Stepped Wedge Cluster Randomised Controlled Trial to Determine the Effectiveness of the Goals of Care Initiative

The Christie NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2019年6月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
220
试验地点
2
主要终点
Decision Conflict Scale

研究概览

简要总结

A single site hybrid implement-evaluation stepped wedge cluster randomised controlled trial in which cancer cluster groups (lung, colorectal, breast, renal, ovarian, upper GI & sarcoma) are randomised sequentially to initiate the Goals of Care Initiative into clinical practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing, or being considered for, systemic treatment from one of the cluster teams.
  • 18+ years.
  • Able to give written consent.
  • Able to understand verbal and written English.

排除标准

  • Patient is not being considered for Systemic Anti-Cancer Treatment.

结局指标

主要结局

Decision Conflict Scale

时间窗: Immediately following intervention

Patient satisfaction with decision and overall decision conflict will be measured using the Ottawa Decisional Conflict Scale. The scale consists of 16 items with patients scoring themselves on a five point scale (0, Strongly Agree - 4, Strongly Disagree). The scale includes five subscales: uncertainty, support, values, informed, effective decision. The total score and subscale scores are calculated by dividing the sum of the items by the number of items within that subscale and multiplying by twenty five (scored range from 0 to 100; 0 score indicates no decisional conflict, 100 indicates extremely high decisional conflict). This scale evaluates the quality of decision as outlined within internationally recognised guidelines to establish the effectiveness of decision aids. Furthermore, some of the subscales address evaluating the quality of the decision process (feeling informed about the options, clarity of values).

SDM-Q-9

时间窗: Immediately following intervention

Patient involvement in decision making will be measured using the SDM-Q-9 questionnaire. The questionnaire contains nine items with respondents scoring on a six point scale (0 represents completely disagree to 5 which represents completely disagree) how much they agree with the presented statement. The highest score attainable, 45, represents the highest level of perceived Shared Decision Making and 0 represents no perceived involvement in Shared Decision Making.

次要结局

  • Decision Self Efficacy Scale(Immediately following intervention, then at 6 weeks and 12 weeks.)
  • EQ-5D-5L(Immediately following intervention, then at 6 weeks and 12 weeks.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验